BioCardia, Inc.
BCDA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $8,098,424 | $9,866 | $6,970 | $5,982 |
| - Cash | $5,287 | $980 | $949 | $2,371 |
| + Debt | $638 | $745 | $850 | $951 |
| Enterprise Value | $8,093,775 | $9,631 | $6,871 | $4,562 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$107 | -$1,368 | -$1,530 | -$1,415 |
| % Margin | – | – | – | – |
| EBITDA | -$1,376 | -$2,046 | -$2,714 | -$2,306 |
| % Margin | – | – | – | – |
| Net Income | -$1,483 | -$2,049 | -$2,712 | -$2,296 |
| % Margin | – | – | – | – |
| EPS Diluted | -236.23 | -0.4 | -0.99 | -0.5 |
| % Growth | -58,957.5% | 59.6% | -98% | – |
| Operating Cash Flow | -$1,672 | -$1,649 | -$1,618 | -$2,573 |
| Capital Expenditures | $0 | -$1 | $0 | -$1 |
| Free Cash Flow | -$1,672 | -$1,650 | -$1,618 | -$2,574 |